Libor Vı́tek
-
- Neonatal Health and Biochemistry 106
- Molecular Biology top 1%
- Heme Oxygenase-1 and Carbon Monoxide 115
- Hepatology top 2%
- Cell Biology top 2%
- Hemoglobin structure and function 21
-
- Alcohol Consumption and Health Effects 17
-
- Drug Transport and Resistance Mechanisms 28
-
- Liver Disease Diagnosis and Treatment 24
-
- Methemoglobinemia and Tumor Lysis Syndrome 22
-
- Pediatric Hepatobiliary Diseases and Treatments 12
- Co-authors
- Harvey A. SchwertnerLadislav NovotnýClaudio TiribelliLucie MuchováJ. Donald OstrowJaroslav ZelenkaMartin LeníčekMartin Haluzı́k
- Journals
- Scientific Reports (13 papers)International Journal of Molecular Sciences (7 papers)PLoS ONE (7 papers)
- Partner nations
- CzechiaUnited StatesItaly
In The Last Decade
Libor Vı́tek
241 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Pediatrics, Perinatology and Child Health 3.1k
- Molecular Biology 4.5k
- Hepatology 339
- Cell Biology 688
- Pathology and Forensic Medicine 616
Countries citing papers authored by Libor Vı́tek
This map shows the geographic impact of Libor Vı́tek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libor Vı́tek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libor Vı́tek more than expected).
Fields of papers citing papers by Libor Vı́tek
This network shows the impact of papers produced by Libor Vı́tek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libor Vı́tek. The network helps show where Libor Vı́tek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Libor Vı́tek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 14 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 39 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 39 | |
| 11 | 2018 | 5 | |
| 12 | 2018 | 28 | |
| 13 | 2017 | 10 | |
| 14 | 2016 | 6 | |
| 15 | 2015 | 26 | |
| 16 | 2013 | 11 | |
| 17 | 2012 | 16 | |
| 18 | 2012 | 6 | |
| 19 | 2010 | 88 | |
| 20 | Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies. | 1998 | 36 |
About Libor Vı́tek
Libor Vı́tek is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Hepatology, having authored 246 papers that have together received 7.6k indexed citations. Recurring topics across this work include Heme Oxygenase-1 and Carbon Monoxide (115 papers), Neonatal Health and Biochemistry (106 papers), Drug Transport and Resistance Mechanisms (28 papers), Liver Disease Diagnosis and Treatment (24 papers), Methemoglobinemia and Tumor Lysis Syndrome (22 papers), Hemoglobin structure and function (21 papers), Alcohol Consumption and Health Effects (17 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.1k citations), Molecular Biology (4.5k citations) and Hepatology (339 citations). Libor Vı́tek has collaborated with scholars based in Czechia, United States and Italy. Frequent co-authors include Harvey A. Schwertner, Ladislav Novotný, Claudio Tiribelli, Lucie Muchová, J. Donald Ostrow, Jaroslav Zelenka, Martin Leníček, Martin Haluzı́k, Martin C. Carey and Petr Klán. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences, PLoS ONE, Physiological Research and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.